In conclusion, this study demonstrated that the CASC19-regulated protective autophagy through the AMPK/mTOR pathway made a major contribution to the radioresistance of NPC cells (Figure 7), suggesting that CASC19 may represent an attractive therapeutic target to improve radiotherapy against NPC. The gene discussed is MTOR; the disease is nasopharyngeal carcinoma.